Zebra Biologics
Concord, US · Founded 2013 · Delaware corporation
Founders & leadership
RM
Ronald M. LindsayExecutive
RA
Richard A. LernerNamed on SEC filing
Board
PF
Phillip FrostBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedDec 2015 · 4 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Phillip FrostDirector
- Ronald M. LindsayExecutive Officer, Director
- Richard A. LernerDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $308.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $210.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $304.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- How much funding has Zebra Biologics raised?
- Zebra Biologics has disclosed $3M raised across 1 round.
- Where is Zebra Biologics headquartered?
- Zebra Biologics is headquartered in Concord, US.